CRT 2024
Innovation
Renal Denervation and Hypertension Therapies [Non-CME]
Vasilios Papademetriou, MD, DSc
Director Interventional Hypertension and Vascular Medicine
Georgetown University/VAMC
Washington, District of Columbia, United States
No relationships to disclose
Eric A. Secemsky, MD, MSc
Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure information not submitted.
Michael Weber, MD
Professor of Medicine
SUNY Downstate Medical College
Palm Beach Gardens, Florida, United States
No relationships to disclose
Justin E. Davies, MD, PhD
Cardiologist
Imperial College London
London, England, United Kingdom
No relationships to disclose
Tim A. Fischell, MD, FACC
Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States
Disclosure information not submitted.
Rich R. Heuser, MD, MSCAI
Interventional Cardiologist
Heart and Vascular Center of Arizona
Phoenix, Arizona, United States
Disclosure information not submitted.
David E. Kandzari, MD, FACC, FSCAI
Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure information not submitted.
Felix Mahfoud, MD
Professor
Saarland University Hospital
Homburg/Saar, Saarland, Germany
No relationships to disclose
John P. Reilly, MD
Chief of Cardiology
Stony Brook Southampton Hospital
Stony Brook, New York, United States
No relationships to disclose
Judith Veis, MD
Section Director, Nephrology
Medstar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): No financial relationships to disclose
Jie Wang, MD, PhD
Professor
Jiangsu Province Hospital
Nanjing, Jiangsu, China (People's Republic)
Disclosure information not submitted.
William S. Weintraub, MD
Cardiologist
MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure information not submitted.